Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANVAS: Cvac Dendritic Cell Vaccine as Maintenance in Epithelial Ovarian Cancer Remission
2011-000177-31Phase 2Terminated
- Sponsor
- Immutep Limited
- Start
- Feb 2012
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of CVac in Ovarian Epithelial Adenocarcinoma (4 arms), sponsored by Immutep Limited. Started Feb 2012; status: terminated.
02
Drugs
CVac
03
Conditions
Ovarian Epithelial Adenocarcinoma
Beyond the preview
Go deeper on 2011-000177-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000177-31.